Nicotinamide Riboside Ya Ƙara NAD+, Amma Bai Inganta Tunawa ba
Wani ƙara ya ninka matakin NAD+ a jini, amma ba a samu tasiri a kan tunawa ba. A gwajin makonni 12 da aka gudanar kan manya da ke da amnestic mild cognitive impairment (aMCI), nicotinamide riboside ya ninka NAD+ sau biyu, amma ba ya haɓaka aikin kwakwalwa, yawan jinin kwakwalwa, ko hawan jini. An ga alamar ƙaruwa a yawan jinin da ke gudana zuwa hippocampus, amma wannan ba tabbataccen sakamako ba ne. Ga abin da binciken ya nuna, iyakokinsa, da abin da ya ke nufi ga waɗanda ke tunanin ƙara NAD+.
Shekara ɗaya da Spermidine ta ƙara gudun jini a Precuneus, ba a samu ƙaruwa a ƙwaƙwalwa ba
Binciken watanni 12 na shan 0.9 mg na spermidine a manya masu jin ƙarancin tunani ya nuna ƙaruwa a gudun jini na sashin Precuneus da daidaiton tsarin farin ƙashi a cingulate. Sai dai ba a samu canji a girman kwakwalwa, kaurin cortical, ko hyperintensities na farin ƙashi ba, kuma waɗannan canje‑canjen ba su da alaka da ƙwaƙwalwa. Wannan sakamakon yana da ban sha'awa, amma ba ya nuna za a samu ci gaban tunani a yanzu.